Détention brevets de la classe C40B 30/08

Brevets de cette classe: 69

Historique des publications depuis 10 ans

8
2
3
2
10
2
2
2
1
3
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Propriétaires principaux

Proprétaire
Total
Cette classe
HTE GmbH The High Throughput Experimentation Company
62
5
1859, Inc.
15
5
The Regents of the University of California
20720
3
Hypharm GmbH
11
3
The Board of Trustees of the Leland Stanford Junior University
6644
2
National Taiwan University
1324
2
Ginkgo BioWorks, Inc.
260
2
National Health Research Institutes
335
2
The Trustees of Princeton University
1262
2
Cyclenium Pharma Inc.
9
2
Merck Patent GmbH
5725
1
Glaxosmithkline Intellectual Property Development Limited
776
1
California Institute of Technology
4043
1
Life Technologies Corporation
3456
1
The Johns Hopkins University
5875
1
President and Fellows of Harvard College
6091
1
Novozymes A/S
3382
1
Affinity Biosciences Pty Ltd
10
1
AV Therapeutics, Inc.
2
1
Bio-Rad Laboratories, Inc.
1611
1
Autres propriétaires 31